722 related articles for article (PubMed ID: 27306424)
1. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
[TBL] [Abstract][Full Text] [Related]
2. Generation of Insulin-Producing Cells From Human-Induced Pluripotent Stem Cells Using a Stepwise Differentiation Protocol Optimized With Platelet-Rich Plasma.
Enderami SE; Mortazavi Y; Soleimani M; Nadri S; Biglari A; Mansour RN
J Cell Physiol; 2017 Oct; 232(10):2878-2886. PubMed ID: 27925205
[TBL] [Abstract][Full Text] [Related]
3. OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells.
Parenti A; Halbisen MA; Wang K; Latham K; Ralston A
Stem Cell Reports; 2016 Apr; 6(4):447-455. PubMed ID: 26947975
[TBL] [Abstract][Full Text] [Related]
4. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells.
Yabe SG; Fukuda S; Takeda F; Nashiro K; Shimoda M; Okochi H
J Diabetes; 2017 Feb; 9(2):168-179. PubMed ID: 27038181
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
[TBL] [Abstract][Full Text] [Related]
6. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
[TBL] [Abstract][Full Text] [Related]
7. Generation of pig iPS cells: a model for cell therapy.
Montserrat N; Bahima EG; Batlle L; Häfner S; Rodrigues AM; González F; Izpisúa Belmonte JC
J Cardiovasc Transl Res; 2011 Apr; 4(2):121-30. PubMed ID: 21088946
[TBL] [Abstract][Full Text] [Related]
8. Skin Biopsy and Patient-Specific Stem Cell Lines.
Li Y; Nguyen HV; Tsang SH
Methods Mol Biol; 2016; 1353():77-88. PubMed ID: 26141312
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.
Kroon E; Martinson LA; Kadoya K; Bang AG; Kelly OG; Eliazer S; Young H; Richardson M; Smart NG; Cunningham J; Agulnick AD; D'Amour KA; Carpenter MK; Baetge EE
Nat Biotechnol; 2008 Apr; 26(4):443-52. PubMed ID: 18288110
[TBL] [Abstract][Full Text] [Related]
10. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
11. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
[TBL] [Abstract][Full Text] [Related]
12. Successful Derivation of an Induced Pluripotent Stem Cell Line from a Genetically Nonpermissive Enhanced Green Fluorescent Protein-Transgenic FVB/N Mouse Strain.
Abbey D; Singh G; Verma I; Derebail S; Kolkundkar U; Chandrashekar DS; Acharya KK; Vemuri MC; Seshagiri PB
Cell Reprogram; 2019 Oct; 21(5):270-284. PubMed ID: 31596624
[TBL] [Abstract][Full Text] [Related]
13. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
[TBL] [Abstract][Full Text] [Related]
14. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
[TBL] [Abstract][Full Text] [Related]
15. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of Human-Induced Pluripotent Stem Cells Into Insulin-Producing Clusters by MicroRNA-7.
Shaer A; Azarpira N; Karimi MH; Soleimani M; Dehghan S
Exp Clin Transplant; 2016 Oct; 14(5):555-563. PubMed ID: 26103160
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
19. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism.
Martinez-Fernandez A; Nelson TJ; Yamada S; Reyes S; Alekseev AE; Perez-Terzic C; Ikeda Y; Terzic A
Circ Res; 2009 Sep; 105(7):648-56. PubMed ID: 19696409
[TBL] [Abstract][Full Text] [Related]
20. Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture.
Zou Q; Wu M; Zhong L; Fan Z; Zhang B; Chen Q; Ma F
PLoS One; 2016; 11(2):e0149023. PubMed ID: 26882313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
